Presentation

First Report of the 12-Month Outcomes of SELUTION Trial: A Novel Sirolimus Coated DCB Technology Evaluated in SFA (MedAlliance)

Presenter: Klaus Brechtel

September 21, 2018

REGISTER for free or LOG IN to view this content

First Report of the 12-Month Outcomes of SELUTION Trial: A Novel Sirolimus Coated DCB Technology Evaluated in SFA (MedAlliance)

Coronary

DES/BRS/DCB

Presentation

TCT 2018

Innovation

SELUTION

Up Next

Presentation

Atrial Fibrillation and ACS/PCI: The End of Triple Therapy?

Presenter: Stephan Windecker

September 21, 2018

More slides +

Presentation

Debate: Stents are Still the Best Endovascular Treatment for Long-Segment SFA CTOs!

Presenter: Gary M. Ansel

September 21, 2018

Presentation

Does Aspirin Have a Role in the Management of Patients Undergoing PCI?

Presenter: Patrick W. Serruys

September 21, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.